Molecular Diagnostics
Hereditary Breast Cancer Tests Double Detection Rate
Germline genetic testing in patients newly diagnosed with cancer has the potential to reduce disease burden through secondary prevention and targeted therapies. There is a prerequisite to understand how genetic testing is being integrated into practice for patients newly diagnosed with cancer and the impact of results on treatment decisions. More...23 May 2018
Genetic Variations Increase Heart Attack Risk for Statin Patients
Coronary heart disease (CHD) is a leading cause of death globally. Although therapy with HMG-CoA reductase inhibitors (statins) decreases circulating levels of low-density lipoprotein cholesterol (LDL-C) and the incidence of CHD, additional events occur despite statin therapy in some individuals. More...22 May 2018
Genetic Predisposition Validated in Medulloblastoma
Medulloblastoma is a rare malignant tumor of the brain and occurs predominantly in children and is associated with rare hereditary cancer predisposition syndromes. It is believed that in many cases hereditary gene defects trigger the development of this malignant disease. More...22 May 2018
Specific Biomarker Discovered for Rheumatoid Arthritis
Rheumatoid arthritis (RA) is an autoimmune disorder that occurs when the immune system mistakenly attacks the body's tissues. Unlike the wear-and-tear damage of osteoarthritis, rheumatoid arthritis affects the lining of the joints, causing painful swelling that can eventually result in bone erosion and joint deformity. More...22 May 2018
Tool Predicts Deadly Form of Mycosis Fungoides
Mycosis fungoides (MF), the most common cutaneous T cell lymphoma (CTCL) is a malignancy of skin-tropic memory T cells. Most MF cases present as early stage (stage I A/B, limited to the skin), and these patients typically have a chronic, indolent clinical course. More...21 May 2018
Factors Affecting Plasma DNA Analysis Evaluated
There is vast potential in precision-medicine methods of both detecting and monitoring disease by looking for indications of cancer mutations in cell-free DNA (cfDNA), circulating in the blood. However, there are many factors that can significantly alter these samples as they are collected and analyzed. More...21 May 2018
Near-Patient Hepatitis C Assay Validated
Chronic infection with hepatitis C virus (HCV) is a major public health problem, estimated to infect 1.0% of the world’s population (71 million people) and to be responsible for 400, 000 annual deaths as a result of cirrhosis and liver cancer. More...17 May 2018
Gold Member
Aspiration System
VACUSAFE
Immunofluorescence Analyzer
IFA System
HPV Molecular Test
BD Onclarity HPV Assay
In Other News
Molecular Subtype Identified for CRCs Metastasized to Liver
Familial Genetics Influence Migraine Type
Kidney Disease Patient Urine Contains Diverse Bacteria
Genetic Scores Stratify Risk of Developing Type 1 Diabetes
Assays Using ddPCR Quantify DNA Fragments
EBV Protein Implicated in Autoimmune Diseases
Molecular Tests Equivalent to Bone Marrow Analysis for MM
Thyroid Cancer Genetics Study Finds New Mutations
Diagnostic SHERLOCK Optimized for Rapid Viral Detection
Streamlined Approach Discovered for Treating Bowel Cancer
Metagenomic Sequencing Can Diagnose Cases of Meningitis
Clostridium difficile Examined by Different Methods
Treponemal Subspecies Discriminated by LAMP
Molecular Technology Identifies Potential Biomarker for Cancer
Assay Detects Hepatitis B in Multiple Specimens
Genetic Variant Identified As Better Marker for CV Disease
CSF Examined for Enteroviral Nervous System Infection
Blood Test Predicts Onset of TB in Advance
Genetic Link to IBS Identified in Women
Genetic Test May Improve Post-Stent Treatment Outcome
Amino Acids Can Predict CV Disease Risk in Women
Rapid Test Developed for Hepatitis C Infections
Nanopore Method Developed for Genetic Screening
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.